Xenon Pharmaceuticals Growth Metrics (2013-2025) | XENE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	-0.03M	-0.10M	-0.02M	-0.09M	0.02M	-0.48M	-2.93M
EBITDA Margin Growth (3y) (Quarter)							-2.94M										-0.07M
EBITDA Margin Growth (5y) (Quarter)	0.06M	0.05M	0.14M	0.08M	4.97M	4.68M	-2.64M										-0.07M
EBITDA Margin (QoQ) (Quarter)	-0.06M	-0.06M	0.07M	-0.03M	0.05M	-0.56M	-2.38M
EBIT Margin Growth (1y) (Quarter)	-0.03M	-0.10M	-0.02M	-0.09M	0.02M	-0.46M	-2.85M
EBIT Margin Growth (3y) (Quarter)							-2.86M										-0.08M
EBIT Margin Growth (5y) (Quarter)	0.06M	0.05M	0.14M	0.08M	4.97M	4.70M	-2.56M										-0.09M
EBIT Margin (QoQ) (Quarter)	-0.06M	-0.06M	0.07M	-0.03M	0.05M	-0.55M	-2.32M
EBT Margin Growth (1y) (Quarter)	-0.03M	-0.10M	-0.02M	-0.04M	0.01M	-0.48M	-2.82M
EBT Margin Growth (3y) (Quarter)							-2.83M										-0.06M
EBT Margin Growth (5y) (Quarter)	0.06M	0.05M	0.14M	0.07M	4.88M	4.61M	-2.54M										-0.08M
EBT Margin (QoQ) (Quarter)	-0.01M	-0.06M	0.07M	-0.03M	0.04M	-0.56M	-2.28M
Enterprise Value Growth (1y) (Quarter)	-19.61%	-28.49%	-30.74%	-211.74%	-95.83%	-202.56%	-155.66%	-7.31%	2.03%	31.54%	17.47%	-7.77%	-32.74%	-33.72%	-24.18%	1.75%	21.44%	32.43%	-39.60%	12.45%
Enterprise Value Growth (3y) (Quarter)	-98.58%	-60.28%	-25.22%	-66.61%	-69.52%	-97.83%	-88.95%	-61.20%	-31.90%	-38.58%	-40.25%	-53.33%	-36.56%	-40.43%	-37.86%	-4.35%	-0.72%	14.80%	-12.68%	2.49%
Enterprise Value Growth (5y) (Quarter)	-37.42%	-38.71%	-29.14%	-53.79%	-56.11%	-72.44%	-70.90%	-68.44%	-71.93%	-53.52%	-32.88%	-39.84%	-44.66%	-47.95%	-47.21%	-34.70%	-19.07%	-19.18%	-36.75%	-25.40%
Enterprise Value (QoQ) (Quarter)	-55.20%	5.16%	4.18%	-121.04%	2.51%	-46.53%	19.04%	7.22%	10.99%	-2.38%	2.40%	-21.15%	-9.64%	-3.14%	9.36%	4.15%	12.33%	11.30%	-87.27%	39.88%
FCF Margin Growth (1y) (Quarter)	-0.03M	-0.05M	-0.02M	-0.03M	0.03M	-0.26M	-2.30M
FCF Margin Growth (3y) (Quarter)							-2.31M										-0.06M
FCF Margin Growth (5y) (Quarter)	0.04M	0.07M	0.08M	0.07M	4.10M	4.28M	-2.01M										-0.06M
FCF Margin (QoQ) (Quarter)	-0.02M	-0.01M	0.03M	-0.02M	0.04M	-0.30M	-2.01M
Interest Coverage Ratio Growth (1y) (Quarter)
Interest Coverage Ratio Growth (5y) (Quarter)
Interest Coverage Ratio (QoQ) (Quarter)
Net Margin Growth (1y) (Quarter)	-0.02M	-0.10M	-0.02M	-0.04M	0.01M	-0.48M	-2.78M
Net Margin Growth (3y) (Quarter)							-2.79M										-0.06M
Net Margin Growth (5y) (Quarter)	0.06M	0.05M	0.14M	0.07M	4.68M	4.61M	-2.49M										-0.08M
Net Margin (QoQ) (Quarter)	-0.01M	-0.06M	0.06M	-0.03M	0.05M	-0.56M	-2.23M
Operating Margin Growth (1y) (Quarter)	-0.03M	-0.10M	-0.02M	-0.09M	0.02M	-0.46M	-2.85M
Operating Margin Growth (3y) (Quarter)							-2.86M										-0.08M
Operating Margin Growth (5y) (Quarter)	0.06M	0.05M	0.14M	0.08M	4.97M	4.70M	-2.56M										-0.09M
Operating Margin (QoQ) (Quarter)	-0.06M	-0.06M	0.07M	-0.03M	0.05M	-0.55M	-2.32M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00
Return on Assets Growth (5y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	0.00M	32.00	-105.00	-0.00M	-746.00	92.00	274.00	216.00	-809.00	-0.00M	-0.00M	-967.00	-185.00	31.00	41.00	-867.00	-0.00M	-0.00M	-0.00M	0.00M
Return on Capital Employed Growth (3y) (Quarter)	0.01M	0.01M	0.00M		0.00M	0.00M	0.00M	0.00M	467.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	846.00
Return on Capital Employed Growth (5y) (Quarter)	793.00	0.00M	0.00M	0.00M				0.01M	0.01M	0.00M	906.00		0.00M	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-456.00
Return on Capital Employed (QoQ) (Quarter)	-257.00	-714.00	-290.00	-256.00	514.00	124.00	-109.00	-314.00	-511.00	-510.00	-357.00	411.00	271.00	-293.00	-348.00	-497.00	-392.00	-741.00	-946.00	0.00M
Return on Equity Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (3y) (Quarter)	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00
Return on Equity Growth (5y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Invested Capital Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Invested Capital Growth (3y) (Quarter)					0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Invested Capital Growth (5y) (Quarter)													0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Invested Capital (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Sales Growth (1y) (Quarter)	-3.00	-10.00	-2.00	-4.00	1.00	-48.00	-278.00	6.00									12.00	148.00
Return on Sales Growth (3y) (Quarter)							-279.00	3.00					-17.00	-176.00			-6.00	20.00	240.00	-47.00
Return on Sales Growth (5y) (Quarter)	6.00	5.00	14.00	7.00	488.00	461.00	-249.00	497.00									-8.00	-38.00	-40.00	-45.00
Return on Sales (QoQ) (Quarter)	-1.00	-6.00	7.00	-3.00	5.00	-56.00	-223.00	281.00						-165.00				-29.00	-4.00	-5.00

Research Tools

Xenon Pharmaceuticals Growth Metrics (2013-2025) | XENE

Create an account

Sign In

Reset Password